3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
22
Carcinoma, Non-Small-Cell Lung
10
Neoplasm Metastasis
6
Lung Neoplasms
6
Brain Neoplasms
6
Colorectal Neoplasms
5
Skin Neoplasms
4
Neoplasms
4
Triple Negative Breast Neoplasms
3
Thyroid Neoplasms
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Breast Neoplasms
3
Uveal Melanoma
2
Multiple Myeloma
2
Lymphoma
2
Leukemia, Hairy Cell
2
Hematologic Neoplasms
2
Glioma
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Diseases
1
Stomach Neoplasms
1
Solid Tumors
1
Soft Tissue Neoplasms
1
Skin Diseases
1
Rectal Neoplasms
1
Interventions
Carboplatin
9
pembrolizumab
7
Pemetrexed
7
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Radiation
4
Nivolumab
4
Bevacizumab
4
Platinum
3
Paclitaxel
3
Mastectomy, Segmental
3
Cisplatin
3
Biopsy
3
fludarabine phosphate
2
durvalumab
2
capmatinib
2
aldesleukin
2
Taxes
2
Radiotherapy, Conformal
2
Radiosurgery
2
Ipilimumab
2
Interleukin-2
2
Immunoglobulin G
2
Disulfides
2
Cyclophosphamide
2
CTLA-4 Antigen
2
Anterior Temporal Lobectomy
2
1,2-diaminocyclohexaneplatinum II citrate
2
veliparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma of Lung
×
binimetinib
×
1 year
×
Clear all
No trials found.